The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bayer; Tilos Therapeutics; TwoXAR
Research Funding - Bayer; Bristol-Myers Squibb; Exelixis; Leap Therapeutics; Merrimack
A phase II study of cabozantinib (cabo) alone or in combination with trastuzumab (T) in patients (pts) with breast cancer brain metastases (BCBM).
 
Jose Pablo Leone
No Relationships to Disclose
 
Jiani Hu
No Relationships to Disclose
 
William Thomas Barry
Research Funding - Pfizer (Inst)
Other Relationship - ARMO BioSciences
 
Dan G. Duda
No Relationships to Disclose
 
Elizabeth Robins Gerstner
No Relationships to Disclose
 
Rakesh K. Jain
Leadership - Tekla Capital Management; Tekla Capital Management; Tekla Capital Management; Tekla Capital Management; XTuit Pharmaceuticals
Stock and Other Ownership Interests - Enlight Biosciences; Ophthotech; SynDevRx; XTuit Pharmaceuticals
Consulting or Advisory Role - Merck; Ophthotech; Pfizer; Sun Pharma; SynDevRx; XTuit Pharmaceuticals
 
Sally Tan
No Relationships to Disclose
 
Elizabeth S Lawler
No Relationships to Disclose
 
Eric P. Winer
Honoraria - Genentech/Roche; Lilly; Tesaro
Consulting or Advisory Role - InfiniteMD; Leap Therapeutics
Research Funding - Genentech (Inst)
 
Nancy U. Lin
Research Funding - Cascadian Therapeutics; Genentech
Patents, Royalties, Other Intellectual Property - Royalties for chapter in Up-to-Date regarding management of breast cancer brain metastases
 
Sara M. Tolaney
Consulting or Advisory Role - AstraZeneca; Genentech; Lilly; Merck; NanoString Technologies; Nektar; Novartis; Pfizer; Puma Biotechnology
Research Funding - Bristol-Myers Squibb; Eisai; Eisai; Exelixis (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)